Cargando…

Radiation-Induced Uterine Carcinosarcoma after Concurrent Chemoradiotherapy for Cervical Squamous Cell Carcinoma

Objective To describe a case of radiation-induced uterine carcinosarcoma 6 years after a cervical squamous cell carcinoma treatment, which imposed some diagnostic and management challenges. Case Report A 57-year-old woman with a history of pelvic chemoradiotherapy ∼ 6.5 years before the event descri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moreira-Barros, Joana, Huang, Kuan-Gen, Tsai, Tsung-Hsun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Revinter Publicações Ltda 2018
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309298/ https://www.ncbi.nlm.nih.gov/pubmed/30308682 http://dx.doi.org/10.1055/s-0038-1673678

Ejemplares similares

Secondary uterine carcinosarcoma after concurrent chemoradiotherapy for cervical cancer: Case reports
por: Wakayama, Akihiko, et al.
Publicado: (2017)

Elephant leg after treatment for endometrial cancer
por: Moreira-Barros, Joana, et al.
Publicado: (2017)

Lumican is a potential predictor on the efficacy of concurrent chemoradiotherapy in cervical squamous cell carcinoma
por: Hu, Ge, et al.
Publicado: (2023)

Pegylated Liposomal Doxorubicin-induced Palmar-plantar Erythrodysesthesia
por: Moreira-Barros, Joana, et al.
Publicado: (2018)

Spontaneous ureteral rupture during concurrent chemoradiotherapy in a woman with uterine cervical cancer
por: Ikeda, Shun-ichi, et al.
Publicado: (2015)

Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
por: Zhou, Xi-Lei, et al.
Publicado: (2021)

Which is worse: uterine papillary serous carcinomas or carcinosarcomas?
por: Song, Taejong, et al.
Publicado: (2011)

Impact of RhoA overexpression on clinical outcomes in cervical squamous cell carcinoma treated with concurrent chemoradiotherapy
por: Tanaka, Keiichi, et al.
Publicado: (2020)

Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients with cervical nodal necrosis
por: Lan, Mei, et al.
Publicado: (2017)

Cardiac Dose Predicts the Response to Concurrent Chemoradiotherapy in Esophageal Squamous Cell Carcinoma
por: Ho, Yu-Chieh, et al.
Publicado: (2023)

HER2 Oncogene as Molecular Target in Uterine Serous Carcinoma and Uterine Carcinosarcoma
por: McNamara, Blair, et al.
Publicado: (2023)

Effect of BRCA1 on the Concurrent Chemoradiotherapy Resistance of Cervical Squamous Cell Carcinoma Based on Transcriptome Sequencing Analysis
por: Wen, Xin, et al.
Publicado: (2020)

Concurrent chemoradiotherapy with raltitrexed and nedaplatin regimen for esophageal squamous cell carcinoma
por: Qiu, Xiangnan, et al.
Publicado: (2020)

A phase II randomized trial comparing neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in advanced squamous cell carcinoma of the pharynx or larynx
por: Huang, Pei-Wei, et al.
Publicado: (2018)

Comparison of Neoadjuvant Intraarterial Chemotherapy Versus Concurrent Chemoradiotherapy in Patients With Stage IIIB Uterine Cervical Cancer
por: Kawaguchi, Ryuji, et al.
Publicado: (2013)

Case report: Highly differentiated endometrial adenocarcinoma that collided with uterine cervical carcinosarcoma
por: Fan, Xue, et al.
Publicado: (2023)

Trends of uterine carcinosarcoma in the United States
por: Matsuo, Koji, et al.
Publicado: (2018)

Induction chemotherapy with concurrent chemoradiotherapy versus concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of head and neck: a meta-analysis
por: Zhang, Lijuan, et al.
Publicado: (2015)

GALNT14 genotype as a response predictor for concurrent chemoradiotherapy in advanced esophageal squamous cell carcinoma
por: Tsou, Yung-Kuan, et al.
Publicado: (2017)

Port-Site Metastasis of Uterine Carcinosarcoma after Laparoscopy
por: Tan, Zhen, et al.
Publicado: (2017)

The role of squamous cell carcinoma antigen (SCC Ag) in outcome prediction after concurrent chemoradiotherapy and treatment decisions for patients with cervical cancer
por: Fu, Jingxuan, et al.
Publicado: (2019)

Uterine Carcinosarcoma in a Patient with Didelphys Uterus
por: Iavazzo, C., et al.
Publicado: (2013)

Role of TGF-β signaling in uterine carcinosarcoma
por: Dhar Dwivedi, Shailendra Kumar, et al.
Publicado: (2015)

Identification of distinct molecular subtypes of uterine carcinosarcoma
por: An, Yang, et al.
Publicado: (2017)

Targeting the TGFβ pathway in uterine carcinosarcoma
por: Dwivedi, Shailendra Kumar Dhar, et al.
Publicado: (2020)

Dissecting the Origin of Heterogeneity in Uterine and Ovarian Carcinosarcomas
por: Sertier, Anne-Sophie, et al.
Publicado: (2023)

Fatal pulmonary thromboembolism associated with uterine carcinosarcoma
por: Lodetti, Giorgia, et al.
Publicado: (2023)

The prognostic significance of the heterologous component in uterine carcinosarcomas
por: Can, Behzat, et al.
Publicado: (2023)

Usefulness of Short-Term Imaging and Squamous Cell Carcinoma Antigen to Early Predict Response to Concurrent Chemoradiotherapy in Patients With Cervical Cancer
por: Yoo, Ji Geun, et al.
Publicado: (2022)

MRI Using Artificial Intelligence Algorithm to Evaluate Concurrent Chemoradiotherapy for Local Recurrence and Distant Metastasis of Cervical Squamous Cell Carcinoma
por: Wu, Youyi, et al.
Publicado: (2022)

Pretreatment carcinoembryonic antigen level is a risk factor for para-aortic lymph node recurrence in addition to squamous cell carcinoma antigen following definitive concurrent chemoradiotherapy for squamous cell carcinoma of the uterine cervix
por: Huang, Eng-Yen, et al.
Publicado: (2012)

Concurrent Chemoradiotherapy-Driven Cell Plasticity by miR-200 Family Implicates the Therapeutic Response of Esophageal Squamous Cell Carcinoma
por: Lee, Yu-Cheng, et al.
Publicado: (2022)

Extrafascial hysterectomy after concurrent chemoradiotherapy in locally advanced cervical adenocarcinoma
por: Yang, Jie, et al.
Publicado: (2016)

A rare case of ovarian carcinosarcoma with squamous cell carcinoma
por: Daimon, Atsushi, et al.
Publicado: (2019)

Squamous cell carcinoma with sarcomatoid differentiation or carcinosarcoma of the uterine cervix associated with HPV33 infection: report of a rare case
por: Hrudka, Jan, et al.
Publicado: (2020)

Regarding the study testing the addition of gemcitabine to concurrent chemoradiotherapy in cervical carcinoma: Clarity needed
por: Revannasiddaiah, Swaroop, et al.
Publicado: (2013)

Use of serum squamous cell carcinoma antigen for follow-up monitoring of cervical cancer patients who were treated by concurrent chemoradiotherapy
por: Yoon, Sang Min, et al.
Publicado: (2010)

Prognostic Value of Neutrophil-Related Factors in Locally Advanced Cervical Squamous Cell Carcinoma Patients Treated with Cisplatin-Based Concurrent Chemoradiotherapy
por: Wang, Yan-Yang, et al.
Publicado: (2016)

Optimal radiotherapy dose in cervical esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy: A population based study
por: Li, Chia‐Chin, et al.
Publicado: (2021)

Retracted: MRI Using Artificial Intelligence Algorithm to Evaluate Concurrent Chemoradiotherapy for Local Recurrence and Distant Metastasis of Cervical Squamous Cell Carcinoma
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_002pr6g3isdmoqsfj9en7u6kaf